Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liuwei Shunji Capsule in Diarrhea-predominant Irritable Bowel Syndrome
CTR20131452Phase 2Active
- Sponsor
- Zhende Medical
- Start
- Jan 2014
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Liuwei Shunji in Diarrhea-predominant irritable bowel syndrome (IBS-D), sponsored by Zhende Medical. Started Jan 2014; status: active.
02
Drugs
Liuwei Shunji
03
Conditions
Diarrhea-predominant irritable bowel syndrome (IBS-D)
Beyond the preview
Go deeper on CTR20131452.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20131452.